卒中后房颤患者低分子肝素桥接抗凝治疗与不良事件相关

Evidence Based Journals Pub Date : 2019-11-26 DOI:10.1136/ebnurs-2019-103190

Rachel Kennedy

{"title":"卒中后房颤患者低分子肝素桥接抗凝治疗与不良事件相关","authors":"Rachel Kennedy","doi":"10.1136/ebnurs-2019-103190","DOIUrl":null,"url":null,"abstract":"Commentary on: Altavilla R, Caso V, Bandini F, et al . Anticoagulation after stroke in patients with atrial fibrillation. Stroke 2019;508:2093–100.\n\n\n\nPatients with cardioembolic stroke and non-valvular atrial fibrillation are at a high risk of early stroke recurrence.1 Oral anticoagulation therapy (OAC) in the form of vitamin K antagonists (VKAs) and non–vitamin-K oral anticoagulants (NOACs) are the medical therapy of choice in the secondary prevention of …","PeriodicalId":12178,"journal":{"name":"Evidence Based Journals","volume":"38 1","pages":"7 - 7"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events\",\"authors\":\"Rachel Kennedy\",\"doi\":\"10.1136/ebnurs-2019-103190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Commentary on: Altavilla R, Caso V, Bandini F, et al . Anticoagulation after stroke in patients with atrial fibrillation. Stroke 2019;508:2093–100.\\n\\n\\n\\nPatients with cardioembolic stroke and non-valvular atrial fibrillation are at a high risk of early stroke recurrence.1 Oral anticoagulation therapy (OAC) in the form of vitamin K antagonists (VKAs) and non–vitamin-K oral anticoagulants (NOACs) are the medical therapy of choice in the secondary prevention of …\",\"PeriodicalId\":12178,\"journal\":{\"name\":\"Evidence Based Journals\",\"volume\":\"38 1\",\"pages\":\"7 - 7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence Based Journals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ebnurs-2019-103190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence Based Journals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ebnurs-2019-103190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

注释:Altavilla R, Caso V, Bandini F，等。房颤患者脑卒中后抗凝。中风508:2093 2019;100年。心源性卒中和非瓣膜性房颤患者是卒中早期复发的高危人群口服抗凝治疗(OAC)形式的维生素K拮抗剂(VKAs)和非维生素K口服抗凝剂(NOACs)是二级预防…

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events

Commentary on: Altavilla R, Caso V, Bandini F, et al . Anticoagulation after stroke in patients with atrial fibrillation. Stroke 2019;508:2093–100. Patients with cardioembolic stroke and non-valvular atrial fibrillation are at a high risk of early stroke recurrence.1 Oral anticoagulation therapy (OAC) in the form of vitamin K antagonists (VKAs) and non–vitamin-K oral anticoagulants (NOACs) are the medical therapy of choice in the secondary prevention of …

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Evidence Based Journals

自引率

0.00%

发文量